IP Library › Assignment 065316/0412
Patent Assignment
Reel/Frame 065316/0412

Assignment of Assignor's Interest

Recorded: 2023-10-24 Pages: 7
Assignor
NYMOX CORPORATION
Executed: 2023-10-13
Assignee
AVERBACK, PAUL
PRINCESS CHARLOTTE 13, MONACO, 98000, MONACO
Covered Properties (19)
Method of Inducing Selective Prostate Glandular Pharmaco-Ablation with Sparing of Nerves and Preservation of Sexual Function
Application: 16/110,549 →
Publication: US 2020/0061150
Method of Improving Lower Urinary Tract Symptoms
Application: 16/410,685 →
Publication: US 2020/0360466
Method of Enhancing the Therapeutic Efficacy of Fexapotide Triflutate in Treating Luts
Application: 17/557,951 →
Publication: US 2022/0226424
Combination Compositions for Treating Disorders Requiring Removal or Destruction of Unwanted Cellular Proliferations
Application: 14/738,551 →
Publication: US 2016/0361380
Combination Bph Therapy with Fexapotide Triflutate, a 5-Ari, and an Alpha Blocker
Application: 18/161,922 →
Publication: US 2024/0252516
Method of Treating Disorders Requiring Destruction or Removal of Cells
Application: 14/606,683 →
Publication: US 2016/0215031
Method of Preventing or Reducing the Incidence of Acute Urinary Retention
Application: 15/222,365 →
Publication: US 2018/0028597
Method of Preventing or Reducing the Progression of Prostate Cancer
Application: 15/185,344 →
Publication: US 2017/0360885
Compositions and Methods for Improving Sexual Function
Application: 15/446,406 →
Publication: US 2018/0250355
Method of Ameliorating or Preventing the Worsening or the Progression of Symptoms of Bph
Application: 15/258,786 →
Publication: US 2018/0064785
Method of Treating Benign Prostatic Hyperlasia with Antibiotics
Application: 15/938,920 →
Publication: US 2019/0298731
Method of Treating Lower Urinary Tract Symptoms with Fexapotide Triflutate
Application: 16/410,658 →
Publication: US 2020/0360465
Method of Enhancing the Therapeutic Efficacy of Fexapotide Triflutate in Treating Luts
Application: 16/410,639 →
Publication: US 2020/0360464
Methods of Treating Multifocal Cancer
Application: 16/528,390 →
Publication: US 2021/0033613
Focal Treatment of Prostate Cancer
Application: 16/528,326 →
Publication: US 2021/0030842
Methods of Reducing the Need for Surgery in Patients Suffering from Benign Prostatic Hyperplasia
Application: 14/808,731 →
Publication: US 2017/0020957
Protein and Its Use in Diagnosing Alzheimer's Disease
Patent: 7,544,771 →
Application: 11/064,109 →
Publication: US 2006/0188935
Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells
Patent: 7,745,572 →
Application: 12/484,696 →
Publication: US 2009/0286742
Peptides Effectife in the Treatment of Conditions Requiring the Removal or Destruction of Cells
Patent: 9,243,035 →
Application: 14/091,168 →
Publication: US 2015/0148303
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 13, 2005
From: AVERBACK, PAUL; GEMMELL, JACK
To: NYMOX CORPORATION
Reel/Frame 016691/0121 →
Assignment of Assignor's Interest Jun 17, 2009
From: MAHESHWARI, SHAILESH
To: QUALCOMM INCORPORATED
Reel/Frame 022840/0331 →
Assignment of Assignor's Interest Nov 17, 2010
From: NYMOX PHARMACEUTICAL CORPORATION
To: NYMOX CORPORATION
Reel/Frame 025368/0962 →
Assignment of Assignor's Interest Nov 17, 2010
From: AVERBACK, PAUL; GEMMELL, JACK
To: NYMOX PHARMACEUTICAL CORPORATION
Reel/Frame 025368/0864 →
Assignment of Assignor's Interest Dec 15, 2014
From: AVERBACK, PAUL; GEMMELL, JACK
To: NYMOX CORPORATION
Reel/Frame 034508/0765 →
Assignment of Assignor's Interest Feb 1, 2016
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 037635/0684 →
Assignment of Assignor's Interest Mar 28, 2016
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 038116/0062 →
Assignment of Assignor's Interest Apr 30, 2016
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 038430/0703 →
Assignment of Assignor's Interest Jun 20, 2016
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 038956/0237 →
Assignment of Assignor's Interest Nov 4, 2016
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 040224/0606 →
Assignment of Assignor's Interest Jan 26, 2017
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 041088/0467 →
Assignment of Assignor's Interest Sep 7, 2017
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 043523/0671 →
Assignment of Assignor's Interest Nov 15, 2018
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 047512/0382 →
Assignment of Assignor's Interest Nov 19, 2018
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 047537/0608 →
Assignment of Assignor's Interest Aug 30, 2019
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 050226/0362 →
Assignment of Assignor's Interest Aug 30, 2019
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 050226/0578 →
Assignment of Assignor's Interest Sep 5, 2019
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 050282/0964 →
Assignment of Assignor's Interest Sep 25, 2019
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 050490/0434 →
Assignment of Assignor's Interest Sep 27, 2019
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 050512/0920 →
Assignment of Assignor's Interest Dec 21, 2021
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 058448/0891 →
Assignment of Assignor's Interest Feb 17, 2023
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 062732/0877 →
Conditional Assignment Oct 25, 2023
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 065344/0473 →